Eupoly-3® (DHA and EPA Omega-3)

Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

Eupoly-3® is an omega-3 ingredient providing the long-chain fatty acids DHA and EPA. These marine omega-3s are essential structural and signaling fats, with strong evidence for heart and brain health and for raising the body's omega-3 status.

Studied Dose A serving providing several hundred milligrams of combined DHA and EPA per day.
Active Compound Long-chain omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA).

Benefits

Brain and cognition

DHA is a key structural fat in the brain and retina, and DHA and EPA intake is studied for supporting cognition and neural development.

Cardiovascular health

EPA and DHA support healthy triglyceride levels and blood-vessel function, the best-established omega-3 benefit.

Omega-3 status

Supplementation reliably raises plasma and membrane omega-3 levels, a marker of long-term omega-3 sufficiency.

Mechanism of action

1

Membrane incorporation

DHA and EPA are built into cell membranes, supporting their function and serving as precursors to less-inflammatory mediators.

2

Resolution of inflammation

Omega-3s give rise to specialized pro-resolving mediators that help switch off inflammation.

Clinical trials

1
DHA and EPA Intervention and Omega-3 Status — Study
PubMed

Intervention study of DHA and EPA on plasma fatty-acid and related measures. (de la Torre-Aguilar et al. 2022, Frontiers in Nutrition)

Participants supplemented with omega-3.

DHA and EPA supplementation modified plasma fatty-acid profiles, confirming improved omega-3 status.

Side effects and drug interactions

Common Potential side effects

GENERALLY WELL-TOLERATED — omega-3 oils are well tolerated.
Mild fishy aftertaste or burping can occur; take with meals.
Loose stools are possible at higher doses.

Important Drug interactions

Anticoagulants and antiplatelets — high-dose omega-3 may add to bleeding risk; monitor.
Blood pressure medication — possible mild additive lowering.
Tell your doctor before high doses if you have a bleeding disorder.

Frequently asked questions about Eupoly-3® (DHA and EPA Omega-3)

What is Eupoly-3® (DHA and EPA Omega-3)?

Eupoly-3® is an omega-3 ingredient providing the long-chain fatty acids DHA and EPA. These marine omega-3s are essential structural and signaling fats, with strong evidence for heart and brain health and for raising the body's omega-3 status.

What is the recommended dosage of Eupoly-3® (DHA and EPA Omega-3)?

The clinically studied dose for Eupoly-3® (DHA and EPA Omega-3) is A serving providing several hundred milligrams of combined DHA and EPA per day.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Eupoly-3® (DHA and EPA Omega-3) used for?

Eupoly-3® (DHA and EPA Omega-3) is studied for brain and cognition, cardiovascular health, omega-3 status. DHA is a key structural fat in the brain and retina, and DHA and EPA intake is studied for supporting cognition and neural development.

Are there side effects from taking Eupoly-3® (DHA and EPA Omega-3)?

Reported potential side effects may include: GENERALLY WELL-TOLERATED — omega-3 oils are well tolerated. Mild fishy aftertaste or burping can occur; take with meals. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Is Eupoly-3® (DHA and EPA Omega-3) safe to take?

Whether Eupoly-3® (DHA and EPA Omega-3) is safe depends on the dose, your overall health, and any medications you take. At studied doses, reported side effects can include: GENERALLY WELL-TOLERATED — omega-3 oils are well tolerated. It may also interact with certain medications. Eupoly-3® (DHA and EPA Omega-3) is not suitable for everyone — consult a healthcare provider before use if you are pregnant or breastfeeding, have a medical condition, or take prescription medications.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. de la Torre-Aguilar MJ, Gomez-Fernandez A, Flores-Rojas K, et al. Docosahexaenoic and Eicosapentaenoic Intervention Modifies Plasma Fatty Acid Profiles. Front Nutr. 2022;9:790250..PubMedUsed to support: Intervention study confirming omega-3 status change.